Emerging Cell Therapies: Cancer, Autoimmune Diseases, and Beyond

Mar 05–08, 2028 | Fairmont Hotel Vancouver, Vancouver, BC, Canada
Scientific Organizers: Georg A Schett, Marcela V Maus, and Gilles Besin

  Livestream
  In Person
  On Demand
×

-

Mar 05–08, 2028 | Fairmont Hotel Vancouver, Vancouver, BC, Canada

Scientific Organizers: Georg A Schett, Marcela V Maus, and Gilles Besin

Supported by:  

***Meeting program subject to change.

Available Formats:     = Livestream   = In Person     = On Demand
Sunday, March 5, 2028
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, March 6, 2028
Breakfast
7:30–8:30 AM
Welcome Remarks
8:30–8:40 AM
Keynote Address
8:40–9:30 AM
Carl H June †, University of Pennsylvania
A Perspective on the Future of Cell Therapy in Medicine
New Molecular Technologies in Cell Therapy
9:30–11:45 AM
Crystal L. Mackall †, Stanford University
Overcoming Macrophage Mediated Clearance of CAR
Robbie G. Majzner, Dana Farber Cancer Institute
Synthetic Downstream Signaling Molecules in CARs
Aude G. Chapuis †, Fred Hutchinson Cancer Research Center
CD8-Mediated Co-Stimulation to Enhance TCR-Engineered T-Cells
Sònia Guedan, Universitat de Barcelona
Fit to Fight: Engineering CAR-T Cells to Overcome Dysfunction and Tumor Escape
Short Talk(s) Chosen from Abstracts
Coffee Break
10:00–10:20 AM
Meet-the-Editor
11:55–12:55 PM
Poster Setup
12:55–2:00 PM
On Own for Lunch
12:55–2:30 PM
Poster Viewing
2:00–10:00 PM
Symposia Spotlight 1: Efficacy and Safety of Cell Therapy in Autoimmune Disease
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
CAR T-Cell Therapy in Autoimmune Disease
5:00–7:00 PM
Dinesh Khanna, University of Michigan
CAR T-Cell Treatment in Immune-Mediated Fibrotic Diseases
Raffaella Greco †, IRCCS San Raffaele Scientific Hospital
Guidelines for the Treatment of AID by CAR T-Cells
Georg A Schett, Uniklinikum Erlangen
Long-Term Effects of CAR T-Cell in the Treatment of Lupus
Short Talk(s) Chosen from Abstracts
Social Hour with Dinner
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, March 7, 2028
Breakfast
7:30–8:30 AM
Poster Setup
8:00–8:30 AM
Poster Viewing
8:15–5:00 PM
New Technologies in Cell Therapy
8:30–11:30 AM
Jeffrey A. Bluestone, University of California, San Francisco
Antigen-Specific CAR Treg in Rheumatoid Arthritis
Aimee S. Payne, Columbia University
Antigen-Specific Cellular Immunotherapies for Autoimmunity: Lessons from Phase 1 Studies
Maximilian F Konig, The Johns Hopkins University School of Medicine
Precision Targeting of Autoreactive B Cells Using Engineered T Cell Receptors
Gilles Besin †, Valerio Therapeutics
Chances of LNP-based CAR Generation in Cancer and Autoimmune Disease
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Lunch
11:30–12:30 PM
Posters
12:00–2:30 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Predictors of Outcomes in CAR T Cells
5:00–7:00 PM
Roni Shouval, Memorial Sloan Kettering Cancer Center
Response Signature in CAR T-Cell Treatment of NH
Juliane Gust, Seattle Children's Research Institute
Neuroimaging of CNS Toxicities after CAR
Angelika Jahreis †, Novartis
Prediction of IEC-HS in Cancer and Autoimmune Diseases
Short Talk(s) Chosen from Abstracts
On Own for Dinner
7:00–8:00 PM
Wednesday, March 8, 2028
Breakfast
7:30–8:30 AM
Advances in Targeting Solid Tumors by CAR
8:30–11:30 AM
Marcela V Maus, Harvard Medical School
Advances in CAR T-Cell Treatment of Pancreatic Cancer
Christopher A. Klebanoff, Memorial Sloan Kettering Cancer Center
Public Neoantigen Targeting using TCR Gene Therapy
Christine E. Brown, Beckman Research Institute, City of Hope
CAR-Therapy of Brain Tumors
Franco Locatelli †, Ospedale Pediatrico Bambino Gesù
Developments in the Treatment of Medulloblastoma by CAR T-Cells
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Panel Discussion: Perspective on in vivo CAR T Cell Therapy in Cancer and Autoimmune Diseases
11:40–12:40 PM
On Own for Lunch
12:40–2:30 PM
Symposia Spotlight 2: New Methods to Foster Efficacy and Predict the Response of Cell Therapy in Cancer
2:30–4:30 PM
Short Talks Chosen from Abstracts
Coffee Available
4:30–5:00 PM
New Disease Targets for CARs
5:00–6:45 PM
Dominic C. Borie †, Cue Biopharma
CAR T-Cell Therapy of Stiff Person Syndrome
James Howard Jr. †, University of North Carolina
CAR T-Cell Therapy of Myasthenia Gravis
Marion Subklewe, LMU - Klinikum of the University of Munich
Targeting Acute Myeloid Leukemia
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
Social Hour with Dinner
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Thursday, March 9, 2028
Departure
12:00–11:59 PM

Subscribe for Updates